Renalytix Valuation
| RNLX Stock | USD 0.15 0.01 6.25% |
Renalytix seems to be overvalued based on Macroaxis valuation methodology. Our model determines the value of Renalytix AI from analyzing the company fundamentals such as Shares Owned By Insiders of 4.51 %, current valuation of 40.06 M, and Return On Equity of -10.73 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Renalytix's valuation include:
Price Book 18.772 | Enterprise Value 40.1 M | Enterprise Value Ebitda (1.36) | Price Sales 9.8506 | Enterprise Value Revenue 17.0332 |
Overvalued
Today
Please note that Renalytix's price fluctuation is out of control at this time. Calculation of the real value of Renalytix AI is based on 3 months time horizon. Increasing Renalytix's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Renalytix is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Renalytix Stock. However, Renalytix's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.15 | Real 0.14 | Target 4.67 | Hype 0.15 | Naive 0.12 |
The intrinsic value of Renalytix's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Renalytix's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Renalytix AI helps investors to forecast how Renalytix stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Renalytix more accurately as focusing exclusively on Renalytix's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Renalytix's intrinsic value based on its ongoing forecasts of Renalytix's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Renalytix's closest peers.
Renalytix Cash |
|
Renalytix Valuation Trend
Analysing the historical paterns of Renalytix's enterprise value and its market capitalization is a good way to estimate and gauge the value of Renalytix AI over time and is usually enough for investors to make rational market timing decisions.
Renalytix Total Value Analysis
Renalytix AI is at this time expected to have valuation of 40.06 M with market capitalization of 22.55 M, debt of 8.54 M, and cash on hands of 32.36 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Renalytix fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
40.06 M | 22.55 M | 8.54 M | 32.36 M |
Renalytix Investor Information
The company recorded a loss per share of 0.62. Renalytix AI had not issued any dividends in recent years. Based on the key measurements obtained from Renalytix's financial statements, Renalytix AI is not in a good financial situation at this time. It has a very high odds of going through financial crisis in December.Renalytix Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Renalytix has an asset utilization ratio of 28.71 percent. This suggests that the Company is making $0.29 for each dollar of assets. An increasing asset utilization means that Renalytix AI is more efficient with each dollar of assets it utilizes for everyday operations.Renalytix Ownership Allocation
Renalytix owns a total of 82.96 Million outstanding shares. Renalytix holds 4.51 pct. of its outstanding shares held by insiders and 4.13 pct. owned by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Renalytix Profitability Analysis
The company reported the previous year's revenue of 2.29 M. Net Loss for the year was (33.46 M) with profit before overhead, payroll, taxes, and interest of 720 K.About Renalytix Valuation
Our relative valuation model uses a comparative analysis of Renalytix. We calculate exposure to Renalytix's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Renalytix's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 156 K | 148.2 K | |
| Pretax Profit Margin | (14.61) | (15.34) | |
| Operating Profit Margin | (12.93) | (13.58) | |
| Net Loss | (14.62) | (15.35) | |
| Gross Profit Margin | 0.07 | 0.06 |
Renalytix Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 108.2 M |
Renalytix Current Valuation Indicators
Valuation refers to the process of determining the present value of Renalytix AI and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Renalytix we look at many different elements of the entity such as Renalytix's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Renalytix, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Renalytix's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Renalytix's worth.Additional Tools for Renalytix Stock Analysis
When running Renalytix's price analysis, check to measure Renalytix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Renalytix is operating at the current time. Most of Renalytix's value examination focuses on studying past and present price action to predict the probability of Renalytix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Renalytix's price. Additionally, you may evaluate how the addition of Renalytix to your portfolios can decrease your overall portfolio volatility.